EGFR R521K
|
CRC
|
EGFR R521K
|
CRC
|
bevacizumab Sensitive: C3 – Early Trials
|
bevacizumab Sensitive: C3 – Early Trials
|
EGFR R521K
|
SCCHN
|
EGFR R521K
|
SCCHN
|
cetuximab Resistant: C3 – Early Trials
|
cetuximab Resistant: C3 – Early Trials
|
EGFR R521K
|
CRC
|
EGFR R521K
|
CRC
|
cetuximab Sensitive: C3 – Early Trials
|
cetuximab Sensitive: C3 – Early Trials
|